Outbreak of NDM-1– and OXA-181–Producing Klebsiella pneumoniae Bloodstream Infections in a Neonatal Unit, South Africa
Rindidzani E. Magobo, Husna Ismail, Michelle Lowe, Wilhelmina Strasheim, Ruth Mogokotleng, Olga Perovic, Stanford Kwenda, Arshad Ismail, Manala Makua, Abram Bore, Rose Phayane, Harishia Naidoo, Tanya Dennis, Makhosazane Ngobese, Wim Wijnant, Nelesh P. Govender
, and
for Baby GERMS-SA1
Author affiliations: National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa (R.E. Magobo, H. Ismail, M. Lowe, W. Strasheim, R. Mogokotleng, O. Perovic, S. Kwenda, A. Ismail, N.P. Govender); University of the Witwatersrand, Johannesburg (O. Perovic, N.P. Govender); National Department of Health, Pretoria (M. Makua); Gauteng Provincial Department of Health, Johannesburg (A. Bore); Tembisa Provincial Hospital, Johannesburg (R. Phayane, H. Naidoo, T. Dennis, M. Ngobese, W. Wijnant); University of Cape Town, Cape Town, South Africa (N.P. Govender); University of Exeter, Exeter, UK (N.P. Govender).
Main Article
Figure 3
Figure 3. Reference laboratory antimicrobial susceptibility profiles of 27 viable Klebsiella pneumoniae isolates from cases of bloodstream infection during a neonatal unit outbreak, South Africa, October 2019–February 2020.
Main Article
Page created: June 22, 2023
Page updated: July 20, 2023
Page reviewed: July 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.